$MRSH

MARSH & MCLENNAN COMPANIES, INC. (MRSH): Results of Operations and Financial Condition

MARSH & MCLENNAN COMPANIES, INC. (MRSH) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 mmc2q2026ex991newsrelease.htm PRESS RELEASE JUNE 30, 2026 Document Marsh 212 345 5000 www.corporate.marsh.com News release Exhibit 99.1 Marsh reports second quarter 2026 results • Revenue Growth of 6%; Underlying Revenue Growth of 5% • GAAP Operating Income Increases 4%

Original reporting
Published Jul 21, 2026, 11:02 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 21, 2026, 11:32 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$MRSH
Bullish
medium confidence
Mentioned
$MRSH
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$MRSHBullishMed
01

Why it matters

Traders can reassess near-term earnings power and capital return expectations based on the disclosed revenue, operating income, EPS, and shareholder actions (buybacks and a dividend increase).

02

Market read

Q2 2026 results show mid-single-digit revenue growth and double-digit adjusted EPS growth, alongside a 10% dividend hike and continued buybacks.

03

What to watch

The release emphasizes adjusted metrics; without details on the excluded items and any segment margin pressure, traders may over-weight the adjusted EPS beat.

Relevance 7/10Novelty 7/10Timing: filed pre-market today with Q2 and six-month results

Background

SEC Form 8-K Item 2.02 includes Marsh’s Q2 2026 earnings release and related financial condition highlights.

Company-level read

Ticker impact

$MRSHBullishMedium confidence
Context

Marsh reported Q2 2026 results with 6% revenue growth and GAAP EPS of $2.63, plus 9% adjusted EPS growth to $2.96.

Expected impact

Likely modest positive bias if the market had expected slower growth or lower EPS, with additional support from the 10% dividend increase and ongoing buybacks.

Evidence & confidence

The filing provides concrete, time-specific financial results and shareholder return actions, but it does not include explicit guidance or consensus comparisons in the provided text.

Market effects

Reinsurance and insurance brokerage demand signals can influence sentiment across risk and reinsurance intermediaries.

International underlying growth (EMEA, Asia Pacific, Latin America) suggests broad-based demand rather than a single-region driver.

As a global broker, results can marginally affect expectations for capital markets and risk-transfer activity.

Counterpoint

Operating income fell 5% for the first six months on a GAAP basis, which could temper enthusiasm despite adjusted EPS growth.

Key entities

  • Marsh & McLennan Companies, Inc.

    Global risk, reinsurance and capital, people and investments, and management consulting firm reporting Q2 2026 results.

  • Guy Carpenter

    Marsh’s reinsurance brokerage unit; revenue declined 2% in Q2 on both GAAP and underlying basis.

  • Mercer

    Marsh’s consulting unit; revenue grew 7% in Q2 on an underlying basis.

Related articles

$MRSHMed

Marsh & McLennan Companies Q2 Earnings Call Highlights

Marsh & McLennan (NYSE:MRSH) reported Q2 results and discussed market conditions on its earnings call. Consulting revenue rose 10% to $2.6B, with adjusted operating income up 11% to $533M. Mercer revenue was $1.6B. Marsh Global Insurance Market Index showed primary commercial rates down 6% in Q2. The company ended with $20.6B debt and $1.7B cash, and expects $5.5B capital deployment in 2026.

$MRSHMed

Marsh (NYSE:MRSH) Exceeds Q2 CY2026 Expectations

Marsh (NYSE:MRSH) reported Q2 CY2026 results. Revenue rose 6.2% year on year to $7.40 billion, exceeding Wall Street’s estimate by 1.8%, and non-GAAP EPS was $2.96, 2.3% above consensus. Adjusted operating margin was 26.9%. Analysts expect revenue growth of 4.2% and full-year EPS to rise from $10.22 to $10.90.

$MRSHHighAI 9/10

Marsh & McLennan Companies (NYSE:MRSH) Stock Price Down 13.1% After Analyst Downgrade

Marsh & McLennan (NYSE:MRSH) fell 13.1% mid-day Wednesday after Piper Sandler cut its price target to $182 from $190 and kept a neutral rating. Shares traded as low as $180.97 and last at $160.70, after closing $185.00; volume rose to 3.04M. The article also cites recent analyst target changes and April 16 quarterly results: $3.29 EPS vs $3.21 consensus on $7.30B revenue.

$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.